| Primary |
| Colorectal Cancer Metastatic |
22.6% |
| Colon Cancer |
14.4% |
| Neoplasm |
9.3% |
| Colorectal Cancer |
8.6% |
| Colon Cancer Metastatic |
6.2% |
| Product Used For Unknown Indication |
3.6% |
| Colon Cancer Stage Iii |
3.5% |
| Medical Diet |
3.4% |
| Neurological Symptom |
3.2% |
| Gastric Cancer |
3.0% |
| Rectal Cancer |
2.9% |
| Biliary Neoplasm |
2.3% |
| Chemotherapy |
2.3% |
| Gastrointestinal Carcinoma |
2.3% |
| Nausea |
2.3% |
| Drug Use For Unknown Indication |
2.2% |
| Neoplasm Malignant |
2.1% |
| Pancreatic Carcinoma |
2.1% |
| Metastasis |
1.8% |
| Nasopharyngeal Cancer |
1.8% |
|
| Vomiting |
20.7% |
| Pyrexia |
11.3% |
| Neutropenia |
9.9% |
| Diarrhoea |
7.0% |
| Febrile Neutropenia |
5.6% |
| Pulmonary Embolism |
5.6% |
| Stomatitis |
4.2% |
| Renal Failure |
3.8% |
| Hypotension |
3.3% |
| Small Intestinal Obstruction |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Non-cardiac Chest Pain |
2.8% |
| Thrombocytopenia |
2.8% |
| Abdominal Pain |
2.3% |
| Disease Progression |
2.3% |
| Gastrointestinal Haemorrhage |
2.3% |
| Hypersensitivity |
2.3% |
| Leukopenia |
2.3% |
| Nausea |
2.3% |
| Pneumonia |
2.3% |
|
| Secondary |
| Colorectal Cancer Metastatic |
20.0% |
| Colorectal Cancer |
18.9% |
| Colon Cancer |
15.8% |
| Drug Use For Unknown Indication |
13.5% |
| Colon Cancer Metastatic |
4.7% |
| Rectal Cancer |
3.4% |
| Hypertension |
3.2% |
| Product Used For Unknown Indication |
2.6% |
| Prophylaxis |
2.5% |
| Gastric Cancer |
2.3% |
| Burkitt's Lymphoma |
2.0% |
| Nausea |
1.7% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Acute Lymphocytic Leukaemia |
1.4% |
| Premedication |
1.3% |
| Pain |
1.2% |
| Rectal Cancer Metastatic |
1.2% |
| Large Intestine Carcinoma |
1.1% |
| Neoplasm |
1.0% |
| Diarrhoea |
0.9% |
|
| Vomiting |
15.6% |
| Respiratory Failure |
12.1% |
| Pyrexia |
8.6% |
| Death |
5.8% |
| Pulmonary Embolism |
5.6% |
| Sepsis |
5.3% |
| Thrombocytopenia |
4.9% |
| Interstitial Lung Disease |
4.8% |
| Neutropenia |
4.6% |
| Diarrhoea |
4.4% |
| White Blood Cell Count Decreased |
3.9% |
| Stomatitis |
3.8% |
| Febrile Neutropenia |
3.4% |
| Weight Decreased |
2.9% |
| Nausea |
2.8% |
| Renal Failure Acute |
2.5% |
| Small Intestinal Obstruction |
2.3% |
| Renal Failure |
2.3% |
| Intestinal Obstruction |
2.2% |
| Neuropathy Peripheral |
2.2% |
|
| Concomitant |
| Colorectal Cancer |
14.6% |
| Drug Use For Unknown Indication |
13.1% |
| Product Used For Unknown Indication |
11.9% |
| Rheumatoid Arthritis |
7.9% |
| Colorectal Cancer Metastatic |
7.6% |
| Colon Cancer |
7.2% |
| Prophylaxis |
5.9% |
| Colon Cancer Metastatic |
4.9% |
| Rectal Cancer |
4.4% |
| Premedication |
3.8% |
| Acute Lymphocytic Leukaemia |
3.4% |
| Hypertension |
2.5% |
| Pain |
2.5% |
| Hiv Infection |
2.2% |
| Chemotherapy |
1.6% |
| Nausea |
1.6% |
| Prophylaxis Against Graft Versus Host Disease |
1.4% |
| Large Intestine Carcinoma |
1.3% |
| Rectal Cancer Metastatic |
1.1% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
|
| Vomiting |
14.2% |
| Neutropenia |
6.3% |
| Pulmonary Embolism |
5.9% |
| Sepsis |
5.7% |
| Interstitial Lung Disease |
5.6% |
| Diarrhoea |
5.3% |
| Pyrexia |
5.1% |
| Thrombocytopenia |
5.1% |
| Disease Progression |
4.8% |
| Death |
4.4% |
| Renal Failure Acute |
4.4% |
| Nausea |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Rash |
4.0% |
| Pneumonia |
3.9% |
| Septic Shock |
3.6% |
| Weight Decreased |
3.5% |
| Dermatitis Acneiform |
3.4% |
| Decreased Appetite |
3.2% |
| Neuropathy Peripheral |
3.2% |
|
| Interacting |
| Colon Cancer |
23.5% |
| Drug Use For Unknown Indication |
23.5% |
| Colon Cancer Metastatic |
17.6% |
| Premedication |
11.8% |
| Blood Cholesterol Increased |
5.9% |
| Chemotherapy |
5.9% |
| Colorectal Cancer |
5.9% |
| Depression |
5.9% |
|
| Jaundice |
16.7% |
| Lethargy |
16.7% |
| Nasal Septum Perforation |
16.7% |
| Pleural Effusion |
16.7% |
| Somnolence |
16.7% |
| Weight Decreased |
16.7% |
|
